The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Intensity Therapeutics Inc’s current trading price is -93.10% away from its 52-week high, while its distance from the 52-week low is 61.90%. The stock’s price range for this period has been between $0.19 and $4.35 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 6.39 million for the day, a number notably higher than the average daily volume of 3.93 million over the last three months.
The present stock price for Intensity Therapeutics Inc (INTS) is $0.3. In the last trading session, the stock made a considerable jump, reaching $5.0 after an opening price of $0.3. The stock briefly fell to $1.5 before ending the session at $0.29.
Intensity Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $4.35 on 09/03/24, while the lowest price for the same period was registered at $0.19 on 08/01/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Intensity Therapeutics Inc (INTS) has experienced a quarterly decline of -27.68% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 14.12M and boasts a workforce of 16 employees.
Intensity Therapeutics Inc: What Analysts Are Saying
As of right now, 4 analysts are rating Intensity Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6574, with a change in price of -1.6290. Similarly, Intensity Therapeutics Inc recorded 2,646,196 in trading volume during the last 100 days, posting a change of -84.45%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for INTS stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.05.
INTS Stock Stochastic Average
Intensity Therapeutics Inc’s raw stochastic average for the past 50 days is presently 23.19%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 65.66%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 65.16% and 64.81%, respectively.
INTS Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -93.02% this year. Over the last six months, there has been a stronger performance of -85.71%. The price of INTS leaped by -2.28% during the last 30 days period. For the last 5-days stocks have improved 3.45%.
